MedTrace Logo

Effects of Chios Mastiha Essential Oil on Cholesterol Levels of Healthy Volunteers

NCT05858372 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-05-15

No results posted yet for this study

Summary

A prospective, randomized, placebo-controlled study was designed to study the hypolipidemic effect of CMO capsules on healthy volunteers with elevated cholesterol levels.

Conditions

Interventions

DIETARY_SUPPLEMENT

Chios Mastiha essential oil

1 soft gel capsule containing 200 mg of CMO and 100 mg of other excipients being medium chain triglycerides, while the shell was made of bovine gelatin and glycerol

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Skylitseio General Hospital of Chios

    collaborator UNKNOWN

  • AHEPA University Hospital

    lead OTHER

Principal Investigators

  • Athanasios Kartalis, MD · Skylitseio General Hospital of Chios, Greece

  • Matthaios Didagelos, MD, PhD · AHEPA University General Hospital, Thessaloniki, Greece

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05858372 on ClinicalTrials.gov